Day: July 31, 2025

MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings

Written by Customer Service on July 31, 2025. Posted in Public Companies.

NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a strategic agreement with TILT Holdings (“TILT”) (CBOE: TILT) (OTCPK: TLLTF) that will expand the distribution of the Company’s award-winning portfolio of medical marijuana products to Pennsylvania. On July 30, 2025, Standard Farms, LLC (“Standard Farms”), a wholly owned subsidiary of TILT, entered into a Management Services Agreement (the “MSA”) with MariMed Advisors, Inc., a Delaware corporation and wholly owned subsidiary of MariMed (the “Manager”). Under the terms of the MSA, effective September 1, 2025, MariMed will assume the day-to-day management of TILT’s Standard Farms cultivation and processing facility in White Haven, Pennsylvania....

Orrön Energy announces the sale of a 76 MW solar project in Germany

Written by Customer Service on July 31, 2025. Posted in Public Companies.

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Saxovent Renewables to sell a 76 MW solar project in Germany, for a total consideration of MEUR 4.0. The consideration paid at closing is MEUR 2.0, with the remaining consideration contingent upon municipal and legislative approvals. The project is located in the northeastern part of Germany, and is being developed as an agrivoltaic (Agri-PV) project, enabling agricultural activities to take place alongside solar power generation. Half of the total consideration of MEUR 4.0 is paid at closing, which is expected imminently. The contingent consideration of MEUR 2.0 is subject to the fulfilment of two conditions: (i) municipal approval of the zoning plan (Satzungsbeschluss) and (ii) EU Commission approval of the German Solar...

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Written by Customer Service on July 31, 2025. Posted in Public Companies.

This Offering Will Not Dilute Quantum BioPharma Shareholders TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced that Unbuzzd Wellness Inc. (the “Company” or “Unbuzzd“), the company behind unbuzzdTM – the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms – today announced the launch of its previously announced Regulation D 506(c) offering to raise up to US$5.0 million to fund growth and establish a path to a possible initial public offering. This will not impact or dilute Quantum BioPharma shareholders. Quantum BioPharma maintains...

Voluntary TSX delisting application

Written by Customer Service on July 31, 2025. Posted in Mergers And Acquisitions.

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Xanadu Mines Ltd (ASX:XAM, TSX:XAM) ACN 114 249 026 (Xanadu or the Company) refers to its previous announcement released on 29 July 2025 (Announcement) regarding the Compulsory Acquisition Notice provided by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) on 25 July 2025, pursuant to which Bastion will exercise its right to compulsorily acquire the remaining Xanadu Shares under the Corporations Act 2001 (Cth) (Compulsory Acquisition). Further to the Announcement, Xanadu provides the following update in relation to its listing on the Toronto Stock Exchange (TSX). As a result of the pending Compulsory Acquisition, Xanadu has applied to voluntarily delist the Xanadu Shares from the Toronto Stock Exchange (TSX). The Compulsory Acquisition qualifies as a near-term liquidity event for which...

Allegro MicroSystems Reports First Quarter 2026 Results

Written by Customer Service on July 31, 2025. Posted in Earnings Releases And Operating Results.

Sales Increased 22% Year-Over-Year to $203 Million MANCHESTER, N.H., July 31, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its first quarter ended June 27, 2025. “We delivered strong first quarter results, with sales of over $203 million, up 22% year-over-year, and led by growth in both e-Mobility and Industrial and Other, increasing 31% and 50% year-over-year, respectively. Non-GAAP EPS was $0.09, increasing nearly 3x year-over-year, demonstrating the significant operating leverage in our business model,” said Mike Doogue, President and CEO of Allegro. “In addition to this strong financial performance, we are encouraged by the positive...

HII Reports Second Quarter 2025 Results

Written by Customer Service on July 31, 2025. Posted in Earnings Releases And Operating Results.

NEWPORT NEWS, Va., July 31, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) today reported results for the second quarter of fiscal 2025. HighlightsSecond quarter revenues were $3.1 billion Second quarter net earnings were $152 million or $3.86 diluted earnings per share New contract awards of $11.9 billion, resulting in record backlog of $56.9 billion Entered into a strategic partnership with C3 AI to expand our use of digital technologies and apply artificial intelligence to accelerate shipbuilding throughput Reaffirming FY25 segment revenue and operating margin guidance1Second Quarter ResultsSecond quarter 2025 revenues of $3.1 billion were up 3.5% from the second quarter of 2024, driven by growth at Newport News Shipbuilding, Mission Technologies and Ingalls Shipbuilding. Operating income in the second quarter of 2025 was $163...

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

Written by Customer Service on July 31, 2025. Posted in Earnings Releases And Operating Results.

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN Announced capped royalty purchase agreement with Sobi under which Apellis receives up to $300 million for 90% of ex-U.S. royalties of Aspaveli® (pegcetacoplan) Generated $178 million in 2Q 2025 revenues, including $171 million in U.S. net product sales SYFOVRE® (pegcetacoplan injection) injection demand grew 6% quarter-over-quarter, with U.S. net product revenue of $151 million Cash and cash equivalents of $370 million as of June 30, 2025; existing cash, $275 million payment from Sobi, and future product sales expected to be sufficient to fund business to sustainable profitability. Management to host conference call today at 8:30 a.m. ETWALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc....

Electra Begins Testing North American Feedstock for Cobalt Refinery

Written by Customer Service on July 31, 2025. Posted in Public Companies.

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces the start of metallurgical testing on cobalt feedstock from two strategic North American sources: the historic Cobalt Camp in Ontario and home to Electra’s refinery, and the Company’s Iron Creek cobalt and copper project in Idaho. The objective of this initiative is to strengthen and diversify Electra’s cobalt refinery feedstock pipeline by integrating domestic sources alongside existing global supply partners. This program supports the development of a robust, flexible, and resilient North American critical minerals supply chain while maintaining strategic relationships with partners such as Glencore and ERG. These domestic sources are intended to supplement Electra’s existing international...

Codere Online Reports Financial Results for the Second Quarter 2025

Written by Customer Service on July 31, 2025. Posted in Public Companies.

Total revenue was €51.4 mm in Q2 2025, while net gaming revenue1 was €54.8 mm in the period, 1% above Q2 2024 (12% in constant currency terms). Mexico revenue was €26.3 mm in Q2 2025, while net gaming revenue was €29.0 mm in the period, 3% above Q2 2024 (23% in constant currency terms). Net loss was €3.1 mm in H1 2025 versus a net loss of €0.2 mm in H1 2024 primarily due to the impact from exchange rates (€3.0 mm loss in H1 2025 versus €4.8 mm gain in H1 2024). Total cash position of €45.2 mm as of June 30, 2025. Reiterating 2025 net gaming revenue outlook of €220-230 million and Adj. EBITDA2 outlook of €10-15 million. Repurchased $0.7 million of the Company’s shares under the Company’s $5.0 million share buyback plan through July 30, 2025.Madrid, Spain and Tel Aviv, Israel, July 31, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO...

Commerce Announces Second Quarter 2025 Financial Results

Written by Customer Service on July 31, 2025. Posted in Earnings Releases And Operating Results.

Second Quarter Total Revenue of $84.4 Million, an Increase of 3% Versus Prior Year. Total ARR of $354.6 Million, an Increase of 3% Versus Prior Year. Enterprise ARR of $269.3 Million, an Increase of 6% Versus Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) — Commerce.com, Inc. (Nasdaq: BIGC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced financial results for its second quarter ended June 30, 2025. Earlier this morning, BigCommerce announced the launch of its new parent brand, Commerce, and that it has officially changed its corporate name to Commerce.com, Inc. (“Commerce” or the “Company”), unifying BigCommerce, Feedonomics and Makeswift...

Day: July 31, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals